$AIM· SEC filing ·

AIM Reports Ampligen Phase‑2 OS 19.7 mo vs 12.5 mo ctrl, PFS 12.6 mo vs 8.6 mo, +22.3 mo OS in low NLR subgroup

AIM ImmunoTech Inc. · Now $0.90

+59% in 3d after detection

Post-detection moves

1h
1d
-1.9%
3d
+59%
7d
-9.8%
30d

Get alerts like this in real time

Push notifications the moment a signal fires. No spam, no crypto, no fluff.

Download for iOS